Aeterna Zentaris to Collaborate with Almac on Companion Dx

Aeterna Zentaris and Almac are entering into a research collaboration to develop a companion diagnostic to be used with Aeterna Zentaris' potential cancer drug.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.